Acupuncture Synergized With Bortezomib Improves Survival of Multiple Myeloma Mice via Decreasing Metabolic Ornithine

Multiple myeloma (MM) is a hematological malignancy worldwide in urgent need for novel therapeutic strategies. Since Velcade (bortezomib) was approved for the treatment of relapsed/refractory MM in 2003, we have seen considerable improvement in extending MM patient survival. However, most patients a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Mengying, Qian, Jinjun, Hao, Feng, Li, Xinying, Wu, Hongjie, Luo, Xian, Xu, Bin, Gu, Chunyan, Yang, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596548/
https://www.ncbi.nlm.nih.gov/pubmed/34804983
http://dx.doi.org/10.3389/fonc.2021.779562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596548/
https://www.ncbi.nlm.nih.gov/pubmed/34804983
http://dx.doi.org/10.3389/fonc.2021.779562

Ejemplares similares